Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-06 03:03 | 2026-02-05 | MANE | Veradermics, Inc | ENRIGHT PATRICK G | Director, 10% owner | Pharmaceutical Preparations | BUY | $17.00 | 1,075,000 | $18,275,000 | 2,053,474 | +109.9% |
| 2025-12-16 04:07 | 2025-12-11 | VERA | Vera Therapeutics, Inc. | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | BUY | $42.50 | 5,882 | $249,985 | 5,882 | +100.0% |
| 2025-10-14 15:59 | 2025-10-09 | ZBIO | Zenas BioPharma, Inc. | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | BUY | $19.19 | 117,255 | $2,250,030 | 11,990 | +100.0% |
| 2025-06-26 03:07 | 2025-06-23 | VERA | Vera Therapeutics, Inc. | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | BUY | $21.11 | 250,000 | $5,277,300 | 3,596,593 | +7.5% |
| 2024-09-27 23:26 | 2024-09-27 | BIOA | BioAge Labs, Inc. | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | BUY | $18.00 | 400,000 | $7,200,000 | 1,710,589 | +30.5% |
| 2024-09-17 03:57 | 2024-09-16 | ZBIO | Zenas BioPharma, Inc. | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | BUY | $17.00 | 440,000 | $7,480,000 | 774,530 | +131.5% |
| 2023-08-16 00:45 | 2023-08-14 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $138.16 | 1,241 | $171,455 | 20,946 | -5.6% |
| 2023-02-09 03:32 | 2023-02-06 | VERA | Vera Therapeutics, Inc. | ENRIGHT PATRICK G | Director, 10% owner | Pharmaceutical Preparations | BUY | $7.00 | 1,714,285 | $11,999,995 | 1,714,285 | +100.0% |
| 2022-11-26 05:33 | 2022-11-22 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $150.45 | 6,974 | $1,049,264 | 0 | -100.0% |
| 2022-08-10 01:12 | 2022-08-08 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $152.33 | 1,089 | $165,883 | 24,086 | -4.3% |
| 2022-04-05 14:22 | 2022-02-10 | VERA | Vera Therapeutics, Inc. | ENRIGHT PATRICK G | Director, 10% owner | Pharmaceutical Preparations | BUY | $15.00 | 333,333 | $4,999,995 | 3,429,927 | +10.8% |
| 2021-05-19 03:14 | 2021-05-18 | VERA | Vera Therapeutics, Inc. | ENRIGHT PATRICK G | Director, 10% owner | Pharmaceutical Preparations | BUY | $11.00 | 909,090 | $9,999,990 | 3,096,594 | +41.6% |
| 2020-11-14 00:56 | 2020-11-12 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $146.72 | 9,929 | $1,456,738 | 20,368 | -32.8% |
| 2020-05-30 02:13 | 2020-05-27 | AIMT | N/A | ENRIGHT PATRICK G | Director | Other | SALE | $0.00 | 7,840 | $0 | 78,401 | -9.1% |
| 2020-03-20 00:03 | 2020-03-17 | AIMT | N/A | ENRIGHT PATRICK G | Director | Other | BUY | $11.36 | 125,000 | $1,420,050 | 70,561 | +100.0% |
| 2020-01-15 00:16 | 2020-01-10 | APTX | N/A | ENRIGHT PATRICK G | Director | Other | BUY | $3.00 | 261,667 | $785,001 | 3,356,746 | +8.5% |
| 2019-08-13 00:50 | 2019-08-09 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $135.65 | 726 | $98,481 | 17,663 | -3.9% |
| 2018-09-07 23:30 | 2018-09-06 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | OPT+S | $168.76 | 10,130 | $1,709,565 | 16,469 | -38.1% |
| 2018-08-14 01:13 | 2018-08-10 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $175.13 | 1,365 | $239,057 | 16,469 | -7.7% |
| 2018-06-26 23:49 | 2018-06-25 | APTX | N/A | ENRIGHT PATRICK G | Director | Other | BUY | $16.00 | 150,000 | $2,400,000 | 3,190,079 | +4.9% |
| 2018-02-27 00:22 | 2018-02-22 | AIMT | N/A | ENRIGHT PATRICK G | Director, 10% owner | Other | BUY | $32.00 | 15,593 | $498,976 | 22,869 | +214.3% |
| 2017-12-14 01:52 | 2017-12-11 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | OPT+S | $139.73 | 9,000 | $1,257,582 | 16,339 | -35.5% |
| 2017-11-22 01:27 | 2017-11-17 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $133.19 | 352 | $46,883 | 1,365 | -20.5% |
| 2017-08-29 01:10 | 2017-08-25 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $148.40 | 351 | $52,088 | 1,717 | -17.0% |
| 2017-08-15 00:17 | 2017-08-11 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $142.37 | 662 | $94,248 | 2,068 | -24.2% |
| 2017-03-20 23:36 | 2017-03-16 | CORT | CORCEPT THERAPEUTICS INC | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $9.94 | 269,955 | $2,683,245 | 114,675 | -70.2% |
| 2017-03-16 01:45 | 2017-03-13 | CORT | CORCEPT THERAPEUTICS INC | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $10.15 | 600,000 | $6,092,940 | 139,630 | -81.1% |
| 2017-03-11 00:22 | 2017-03-08 | CORT | CORCEPT THERAPEUTICS INC | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $9.75 | 750,000 | $7,312,500 | 151,420 | -83.2% |
| 2017-02-28 03:04 | 2017-02-23 | CORT | CORCEPT THERAPEUTICS INC | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $8.81 | 2,500,000 | $22,025,000 | 166,157 | -93.8% |
| 2016-12-07 00:31 | 2016-12-02 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $101.80 | 677 | $68,919 | 1,365 | -33.2% |
| 2016-11-26 05:05 | 2016-11-22 | CORT | CORCEPT THERAPEUTICS INC | ENRIGHT PATRICK G | Director, 10% owner | Pharmaceutical Preparations | SALE | $9.34 | 36,941 | $345,166 | 180,103 | -17.0% |
| 2016-11-22 05:02 | 2016-11-17 | CORT | CORCEPT THERAPEUTICS INC | ENRIGHT PATRICK G | Director, 10% owner | Pharmaceutical Preparations | SALE | $9.56 | 544,100 | $5,199,420 | 180,830 | -75.1% |
| 2016-11-18 00:36 | 2016-11-15 | CORT | CORCEPT THERAPEUTICS INC | ENRIGHT PATRICK G | Director, 10% owner | Pharmaceutical Preparations | SALE | $9.55 | 174,847 | $1,669,614 | 191,522 | -47.7% |
| 2016-08-18 00:25 | 2016-08-15 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $136.45 | 633 | $86,373 | 2,042 | -23.7% |
| 2016-04-01 00:01 | 2016-03-29 | AIMT | N/A | ENRIGHT PATRICK G | Director, 10% owner | Other | BUY | $13.87 | 78,504 | $1,089,133 | 7,513,134 | +1.1% |
| 2016-02-13 00:55 | 2016-02-10 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $117.92 | 10,000 | $1,179,214 | 4,323 | -69.8% |
| 2016-01-08 00:46 | 2016-01-05 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $138.09 | 10,000 | $1,380,890 | 4,519 | -68.9% |
| 2015-12-04 00:29 | 2015-12-01 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $146.67 | 10,424 | $1,528,870 | 1,310 | -88.8% |
| 2015-11-13 00:25 | 2015-11-10 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $135.29 | 10,000 | $1,352,862 | 4,912 | -67.1% |
| 2015-10-07 23:13 | 2015-10-05 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $133.79 | 10,000 | $1,337,860 | 5,108 | -66.2% |
| 2015-09-03 23:03 | 2015-09-01 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $165.99 | 10,000 | $1,659,852 | 5,304 | -65.3% |
| 2015-08-31 23:06 | 2015-08-27 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $167.87 | 425 | $71,345 | 1,734 | -19.7% |
| 2015-08-11 18:29 | 2015-08-11 | AIMT | N/A | ENRIGHT PATRICK G | Director, 10% owner | Other | BUY | $16.00 | 312,500 | $5,000,000 | 7,434,630 | +4.4% |
| 2015-08-12 00:34 | 2015-08-10 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $181.87 | 10,801 | $1,964,355 | 5,500 | -66.3% |
| 2015-07-08 23:03 | 2015-07-06 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $177.11 | 10,000 | $1,771,055 | 5,696 | -63.7% |
| 2015-06-03 23:04 | 2015-06-01 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $178.73 | 10,000 | $1,787,336 | 5,893 | -62.9% |
| 2015-05-13 23:01 | 2015-05-11 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $176.18 | 10,000 | $1,761,796 | 6,089 | -62.2% |
| 2015-04-08 23:05 | 2015-04-06 | JAZZ | Jazz Pharmaceuticals plc | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $169.14 | 10,000 | $1,691,419 | 6,286 | -61.4% |
| 2015-03-24 23:06 | 2015-03-20 | CORT | CORCEPT THERAPEUTICS INC | ENRIGHT PATRICK G | Director, 10% owner | Pharmaceutical Preparations | SALE | $5.75 | 1,089,745 | $6,264,181 | 13,677,121 | -7.4% |
| 2015-03-23 23:06 | 2015-03-19 | ESPR | Esperion Therapeutics, Inc. | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | SALE | $111.66 | 500,000 | $55,831,600 | 18,361 | -96.5% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.